Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > SPECIFIC CANCERS > BRAINUK treatment guidelines - Brain tumours
Cancer service guidance: Improving outcomes for people with brain and other central nervous system tumours - NICE, June 2006
Produced by: National Institute for Health and Clinical Excellence (NICE), June 2006.
Purpose:. Guidance to describe key aspects of services needed to improve outcomes for adults with brain and other central nervous system tumours.
Can be obtained from: The manual, information for the public, and background documents are available to download from the website.
Link to website: www.nice.org.uk/guidance/csgbraincns
Prodigy Guidance: Brain tumour – suspected
Produced by: Sowerby Centre for Health Informatics at Newcastle, 2005
Purpose: This guidance is a direct implementation of the National Institute for Health and Clinical Excellence’s guideline Referral guidelines for suspected cancer: brain and CNS cancer. This guidance does not cover other aspects of the management of patients with brain tumours.
Can be obtained from: The NHS National Library for Health: Clinical Knowledge Summaries website.
Link to website: www.cks.library.nhs.uk/brain_tumour_suspected/in_depth
Temozolomide for the treatment of recurrent malignant glioma (brain cancer) - NICE, April 2001
Produced by: National Institute for Clinical Excellence (NICE), April 2001. Technology Appraisal TA023
Purpose: To provide guidance to health professionals on the use of temozolomide for brain cancer.
Can be obtained from: The full document and a summary of evidence are available by telephoning 0870 1555 455 and quoting the reference number 23698.
Link to website: www.nice.org.uk/guidance/TA23
Content last reviewed: 08 June 2007
Page last modified: 08 June 2007
Page last modified: 08 June 2007